Stock CHOSA CHOSA ONCOLOGY AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Chosa Oncology AB

Equities

CHOSA

SE0007784319

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 23:00:00 31/01/2024 GMT 		5-day change 1st Jan Change
0.53 SEK +51.43% Intraday chart for Chosa Oncology AB -.--% -6.03%
04-30 Chosa Oncology AB Announces Resignation of Lars Hedbys as Chairman CI
03-28 Chosa Oncology Names CFO, Chief Commercial Officer MT

Valuation

Fiscal Period: December 2023
Capitalization 1 -
Enterprise Value (EV) 1 -
P/E ratio -1.46 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
EV / FCF -
FCF Yield -
Price to Book 2.1 x
Nbr of stocks (in thousands) -
Reference price 2 0.5640
Announcement Date 10/05/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023
Net sales - -
EBITDA 1 -0.8891 -8.549
EBIT 1 -1.556 -9.319
Operating Margin - -
Earnings before Tax (EBT) 1 -1.556 -23.75
Net income 1 -1.361 -23.94
Net margin - -
EPS 2 -0.0715 -0.3860
Free Cash Flow - 10.03
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 10/05/24 10/05/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023
Net Debt 1 - -
Net Cash position 1 0.97 8.77
Leverage (Debt/EBITDA) - -
Free Cash Flow - 10
ROE (net income / shareholders' equity) - -165%
ROA (Net income/ Total Assets) - -37.2%
Assets 1 - 64.38
Book Value Per Share 2 0.6100 0.2700
Cash Flow per Share 2 0.0500 0.1400
Capex - -
Capex / Sales - -
Announcement Date 10/05/24 10/05/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
CHOSA ONCOLOGY AB Stock Chosa Oncology AB
-6.03% 3.55M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+20.63% 127B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+23.21% 117B
ARGENX SE Stock argenx SE
+25.30% 27.67B
BIONTECH SE Stock BioNTech SE
-20.17% 20.33B
GENMAB A/S Stock Genmab A/S
-17.08% 16.79B
BEIGENE, LTD. Stock BeiGene, Ltd.
-18.07% 15.63B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+11.92% 14.84B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-47.70% 14.65B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+58.32% 14.43B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. CHOSA Stock
  4. Financials Chosa Oncology AB